Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Developing safe therapies from human pluripotent stem cells.

Literature DB >> 19587662

Developing safe therapies from human pluripotent stem cells.

Melissa K Carpenter¹, Joyce Frey-Vasconcells, Mahendra S Rao.

Abstract

Entities: Species

Mesh：

Year: 2009 PMID： 19587662 DOI： 10.1038/nbt0709-606

Source DB: PubMed Journal: Nat Biotechnol ISSN： 1087-0156 Impact factor: 54.908

× No keyword cloud information.

76 in total

Review 1. Cell therapy and the safety of embryonic stem cell-derived grafts.

Authors: Hannes Hentze; Ralph Graichen; Alan Colman
Journal: Trends Biotechnol Date: 2006-11-03 Impact factor: 19.536

2. Recurrent chromosomal abnormalities in human embryonic stem cells.

Authors: Claudia Spits; Ileana Mateizel; Mieke Geens; Afroditi Mertzanidou; Catherine Staessen; Yves Vandeskelde; Josiane Van der Elst; Inge Liebaers; Karen Sermon
Journal: Nat Biotechnol Date: 2008-11-23 Impact factor: 54.908

3. Induced pluripotent stem cells generated without viral integration.

Authors: Matthias Stadtfeld; Masaki Nagaya; Jochen Utikal; Gordon Weir; Konrad Hochedlinger
Journal: Science Date: 2008-09-25 Impact factor: 47.728

4. Human embryonic stem cells are prone to generate primitive, undifferentiated tumors in engrafted human fetal tissues in severe combined immunodeficient mice.

Authors: Chu-Chih Shih; Stephen J Forman; Peiguo Chu; Marilyn Slovak
Journal: Stem Cells Dev Date: 2007-12 Impact factor: 3.272

5. Gene trap as a tool for genome annotation and analysis of X chromosome inactivation in human embryonic stem cells.

Authors: Sujoy K Dhara; Nissim Benvenisty
Journal: Nucleic Acids Res Date: 2004-07-29 Impact factor: 16.971

6. Transplantation of human embryonic stem cell-derived oligodendrocyte progenitors into rat spinal cord injuries does not cause harm.

Authors: Frank Cloutier; Monica M Siegenthaler; Gabriel Nistor; Hans S Keirstead
Journal: Regen Med Date: 2006-07 Impact factor: 3.806

7. Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formation.

Authors: Anke Brederlau; Ana Sofia Correia; Sergey V Anisimov; Muna Elmi; Gesine Paul; Laurent Roybon; Asuka Morizane; Filip Bergquist; Ilse Riebe; Ulf Nannmark; Manolo Carta; Erik Hanse; Jun Takahashi; Yoshiki Sasai; Keiko Funa; Patrick Brundin; Peter S Eriksson; Jia-Yi Li
Journal: Stem Cells Date: 2006-03-23 Impact factor: 6.277

8. Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts.

Authors: Rutger-Jan Swijnenburg; Sonja Schrepfer; Johannes A Govaert; Feng Cao; Katie Ransohoff; Ahmad Y Sheikh; Munif Haddad; Andrew J Connolly; Mark M Davis; Robert C Robbins; Joseph C Wu
Journal: Proc Natl Acad Sci U S A Date: 2008-08-26 Impact factor: 11.205

9. Transplanted human neurons derived from a teratocarcinoma cell line (NTera-2) mature, integrate, and survive for over 1 year in the nude mouse brain.

Authors: S R Kleppner; K A Robinson; J Q Trojanowski; V M Lee
Journal: J Comp Neurol Date: 1995-07-10 Impact factor: 3.215

10. Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells.

Authors: Madeleine P Ball; Jin Billy Li; Yuan Gao; Je-Hyuk Lee; Emily M LeProust; In-Hyun Park; Bin Xie; George Q Daley; George M Church
Journal: Nat Biotechnol Date: 2009-03-29 Impact factor: 54.908

46 in total

Review 1. At the dawn of a new discovery: the potential of breast milk stem cells.

Authors: Foteini Hassiotou; Peter E Hartmann
Journal: Adv Nutr Date: 2014-11-14 Impact factor: 8.701

2. Individual cell movement, asymmetric colony expansion, rho-associated kinase, and E-cadherin impact the clonogenicity of human embryonic stem cells.

Authors: Li Li; Bill H Wang; Shuai Wang; Lilian Moalim-Nour; Kanishka Mohib; David Lohnes; Lisheng Wang
Journal: Biophys J Date: 2010-06-02 Impact factor: 4.033

Developing safe therapies from human pluripotent stem cells.

Review 1. Cell therapy and the safety of embryonic stem cell-derived grafts.

2. Recurrent chromosomal abnormalities in human embryonic stem cells.

3. Induced pluripotent stem cells generated without viral integration.

4. Human embryonic stem cells are prone to generate primitive, undifferentiated tumors in engrafted human fetal tissues in severe combined immunodeficient mice.

5. Gene trap as a tool for genome annotation and analysis of X chromosome inactivation in human embryonic stem cells.

6. Transplantation of human embryonic stem cell-derived oligodendrocyte progenitors into rat spinal cord injuries does not cause harm.

7. Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formation.

8. Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts.

9. Transplanted human neurons derived from a teratocarcinoma cell line (NTera-2) mature, integrate, and survive for over 1 year in the nude mouse brain.

10. Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells.

Review 1. At the dawn of a new discovery: the potential of breast milk stem cells.

2. Individual cell movement, asymmetric colony expansion, rho-associated kinase, and E-cadherin impact the clonogenicity of human embryonic stem cells.

3. In Vivo Micro-CT Imaging of Human Mesenchymal Stem Cells Labeled with Gold-Poly-L-Lysine Nanocomplexes.

4. Karotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells.

5. Stem cell policy exceptionalism: proceed with caution.

6. Short-term immunosuppression promotes engraftment of embryonic and induced pluripotent stem cells.

Review 7. Concise review: making and using clinically compliant pluripotent stem cell lines.

Review 8. Mesenchymal stem cell treatments in rheumatology: a glass half full?

Review 9. Pluripotent stem cells: immune to the immune system?

10. Albumin and mammalian cell culture: implications for biotechnology applications.